You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 46 No. 6, June 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Clinical and pathological aspects of parkinsonism in Alzheimer's disease. A role for extranigral factors?

J. C. Morris, M. Drazner, K. Fulling, E. A. Grant and J. Goldring
Department of Neurology, Washington University School of Medicine, St Louis, MO 63110.

To examine the natural history and pathogenesis of parkinsonism in Alzheimer's disease, 44 subjects with clearly established senile dementia of the Alzheimer type were studied during a 66-month period. Sixteen subjects (36%) developed idiopathic parkinsonism, and 12 subjects (27%) developed drug-induced parkinsonism; the chief clinical features of both types were bradykinesia and rigidity, but not resting tremor. The presence of parkinsonism was associated with global (rather than selective) cognitive impairment, as determined by psychometric testing, and with more rapid progression to advanced stages of dementia. The pathological correlates of clinical parkinsonism were heterogeneous in 10 subjects with Alzheimer's disease who were examined post mortem. Coexistent Parkinson's disease was observed in five cases and nonspecific nigral degenerative lesions were present in another three; however, two cases had neither histological changes nor reduced neuronal densities in the substantia nigra. These two cases suggested that extranigral lesions, possibly involving mesocortical dopaminergic pathways, may contribute to the development of parkinsonism in subjects with Alzheimer's disease.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Quetiapine for agitation or psychosis in patients with dementia and parkinsonism
Kurlan et al.
Neurology 2007;68:1356-1363.
ABSTRACT | FULL TEXT  

Clinical phenotype of Parkinson disease dementia.
Galvin et al.
Neurology 2006;67:1605-1611.
ABSTRACT | FULL TEXT  

What best differentiates Lewy body from Alzheimer's disease in early-stage dementia?
Tiraboschi et al.
Brain 2006;129:729-735.
ABSTRACT | FULL TEXT  

Motor signs predict poor outcomes in Alzheimer disease
Scarmeas et al.
Neurology 2005;64:1696-1703.
ABSTRACT | FULL TEXT  

The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs
Burns et al.
Neurology 2005;64:1397-1403.
ABSTRACT | FULL TEXT  

Motor signs during the course of Alzheimer disease
Scarmeas et al.
Neurology 2004;63:975-982.
ABSTRACT | FULL TEXT  

Progression of gait disorder and rigidity and risk of death in older persons
Wilson et al.
Neurology 2002;58:1815-1819.
ABSTRACT | FULL TEXT  

Improved Detection of Substantia Nigra Pathology in Alzheimer's Disease
Schneider et al.
J. Histochem. Cytochem. 2002;50:99-106.
ABSTRACT | FULL TEXT  

A clinical role for [123I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies
Yoshita et al.
J. Neurol. Neurosurg. Psychiatry 2001;71:583-588.
ABSTRACT | FULL TEXT  

Extrapyramidal symptoms and signs in Alzheimer's disease: Pravalence and correlation with the first symptom
Tsolaki et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2001;16:268-278.
ABSTRACT  

An algorithm (decision tree) for the management of Parkinson's disease (2001):: Treatment
Olanow et al.
Neurology 2001;56:S1-S88.
FULL TEXT  

Dementia With Lewy Bodies Studied With Positron Emission Tomography
Cordery et al.
Arch Neurol 2001;58:505-508.
ABSTRACT | FULL TEXT  

Hallucinations, delusions, and cognitive decline in Alzheimer's disease
Wilson et al.
J. Neurol. Neurosurg. Psychiatry 2000;69:172-177.
ABSTRACT | FULL TEXT  

Progression of Parkinsonism and Loss of Cognitive Function in Alzheimer Disease
Wilson et al.
Arch Neurol 2000;57:855-860.
ABSTRACT | FULL TEXT  

Predictors of progression in patients with AD and Lewy bodies
Lopez et al.
Neurology 2000;54:1774-1779.
ABSTRACT | FULL TEXT  

Progression of parkinsonian signs in Alzheimer's disease
Wilson et al.
Neurology 2000;54:1284-1289.
ABSTRACT | FULL TEXT  

Preservation of midbrain catecholaminergic neurons in very old human subjects
Kubis et al.
Brain 2000;123:366-373.
ABSTRACT | FULL TEXT  

Motor dysfunction in mildly demented AD individuals without extrapyramidal signs
Goldman et al.
Neurology 1999;53:956-956.
ABSTRACT | FULL TEXT  

Accuracy of the Clinical Diagnoses of Lewy Body Disease, Parkinson Disease, and Dementia With Lewy Bodies: A Clinicopathologic Study
Litvan et al.
Arch Neurol 1998;55:969-978.
ABSTRACT | FULL TEXT  

Obtaining consent for autopsy in dementia research: The Memory and Aging Project experience
Norton and Morris
AM J ALZHEIMERS DIS OTHER DEMEN 1996;11:2-6.
ABSTRACT  

Tardive Dyskinesia in Alzheimer's Disease: Clinical Features and Neuropathologic Correlates
McDaniel et al.
J Geriatr Psychiatry Neurol 1991;4:79-85.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.